Amprenavir is a second generation human immunodeficiency viral protease inhibitor marketed as Agenerase by GlaxoWellcome under license from Vertex Pharmaceuticals.
http://www.pharmaceuticalonline.com/doc/adding-amprenavir-drugs-chromatography-spectrometry-assay-0001?atc~c=771+s=773+r=001+l=a
http://www.pharmaceuticalonline.com/doc/adding-amprenavir-drugs-chromatography-spectrometry-assay-0001?atc~c=771+s=773+r=001+l=a
No comments:
Post a Comment